Clinical Trials on Solid and Hematological Malignancies in Belgium
Total 702 results
-
Jules Bordet InstituteUniversité Libre de Bruxelles; Fondation Kisane; Les Amis de l'InstitutUnknownAdults | Hematological Malignancy | Oral Antineoplastic AgentsBelgium
-
University of LiegeKU Leuven; Amgen; Vrije Universiteit BrusselCompletedHematological MalignanciesBelgium
-
Chroma TherapeuticsCompletedLymphoid Malignancies | Hematological DiseaseFrance, Belgium, Netherlands
-
Universitaire Ziekenhuizen KU LeuvenInstitutul Clinic FundeniCompletedHematological MalignancyBelgium, Romania
-
General Hospital GroeningeCompletedOncology | Haematological MalignancyBelgium
-
University of LiegeKU Leuven; Maastricht University Medical CenterCompletedHematological MalignanciesBelgium, Netherlands
-
EMD SeronoTerminatedHaematological MalignanciesItaly, United States, Switzerland, Belgium, Germany
-
University of LiegeCompletedHematological MalignanciesBelgium
-
SanofiCompletedHematological MalignancyGreece, Spain, Peru, Israel, United States, Argentina, Belgium, Brazil, Chile, Finland, France, Italy, Mexico, Russian Federation, Turkey, Ukraine, United Kingdom
-
Merck Sharp & Dohme LLCRecruitingSolid Tumors | Hematologic MalignanciesUnited States, Poland, Brazil, Ukraine, Argentina, Australia, Austria, Belgium, Canada, Chile, China, Colombia, Czechia, Denmark, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Israel, Italy, Japan, Korea, Republic... and more
-
Incyte CorporationTerminatedSolid Tumors and Hematologic MalignancyUnited States, Netherlands, Belgium
-
University Hospital, GhentCompletedHematological Malignancies | CMV InfectionBelgium
-
University of LiegeCompletedHematologic MalignanciesBelgium
-
University of LiegeUniversity Hospital, Gasthuisberg; University Hospital, Ghent; University Hospital... and other collaboratorsActive, not recruitingHematological Malignancies | Graft-Versus-Host DiseaseBelgium
-
Universitair Ziekenhuis BrusselVrije Universiteit BrusselEnrolling by invitationChildhood Cancer | Hematological DisordersBelgium
-
Janssen Research & Development, LLCRecruitingHematological MalignanciesUnited States, Netherlands, Spain, Belgium
-
Janssen Research & Development, LLCActive, not recruitingHematological MalignanciesCanada, United States, France, Italy, United Kingdom, Germany, Belgium, Netherlands, Spain, Sweden, China
-
PfizerActive, not recruitingOvarian Cancer | NSCLC | Solid Tumors | Urothelial Cancer | Advanced MalignanciesHungary, Spain, United States, Canada, Taiwan, Japan, Serbia, Italy, New Zealand, Australia, Mexico, Russian Federation, United Kingdom, France, Korea, Republic of, Belgium, Poland, Denmark, Israel
-
Janssen Research & Development, LLCRecruitingHematological MalignanciesUnited States, Belgium, Korea, Republic of, China, Germany, Israel, Netherlands, Japan, Spain, France, Poland
-
Kiadis PharmaCompletedAcute Myeloid Leukemia | Acute Lymphoblastic Leukemia | Myelodysplastic SyndromeCanada, Germany, Belgium, United Kingdom
-
Athersys, IncCato ResearchCompletedHematologic MalignanciesUnited States, Belgium
-
Kiadis PharmaCompletedAcute Myeloid Leukemia | Acute Lymphoblastic Leukemia | Myelodysplastic SyndromeCanada, Belgium, Germany, Croatia, United Kingdom, Portugal
-
Blueprint Medicines CorporationRecruitingAdvanced Systemic MastocytosisUnited States, Norway, Netherlands, Belgium, Germany, France, Spain
-
Ziekenhuis Netwerk Antwerpen (ZNA)UnknownUnspecified Adult Solid Tumor, Protocol SpecificBelgium
-
Incyte CorporationRecruitingAdvanced MalignanciesSpain, United States, Belgium, Italy
-
Domain Therapeutics SARecruitingSolid Tumor, AdultFrance, Belgium
-
University Hospital, GhentUniversity Ghent; Het LezerscollectiefCompletedAcute Leukemia | Advanced Solid TumorBelgium
-
SOTIO Biotech AGRecruitingAdvanced Solid Tumor | Metastatic Solid TumorUnited States, Spain, Czechia, Belgium, France
-
Universitaire Ziekenhuizen KU LeuvenB. Braun Medical SA; RITA Medical SystemsCompleted
-
Universitair Ziekenhuis BrusselCompletedSolid Tumor | Metastases to Soft TissueBelgium
-
OSE ImmunotherapeuticsBoehringer IngelheimActive, not recruitingSolid Tumor, AdultFrance, Belgium
-
Xenothera SASRecruitingMetastatic Cancer | Advanced Solid TumorFrance, Belgium
-
Cristal TherapeuticsCompletedCancer | Metastatic Cancer | Solid TumorsNetherlands, Belgium
-
Universitaire Ziekenhuizen KU LeuvenLeuvens Kanker InstituutCompletedHematologic Disease | Oncology, MedicalBelgium
-
Novartis PharmaceuticalsActive, not recruitingAdvanced Malignancies That Harbor IDHR132 MutationsBelgium, Germany, Spain, Canada, Australia, United States, Netherlands, Singapore
-
Janssen Research & Development, LLCCompletedNeoplasms | Neoplasms, Breast | Neoplasms, Ovarian | Advanced or Refractory Solid MalignanciesUnited States, United Kingdom, Spain, Belgium
-
Universitair Ziekenhuis BrusselKom Op Tegen KankerRecruitingBreast Cancer | Melanoma (Skin) | Malignant Solid TumorBelgium
-
Byondis B.V.CompletedSolid TumorsNetherlands, Belgium, United Kingdom, Spain
-
The Belgian Society of Medical OncologyIllumina, Inc.; OncoDNA; PierianDxRecruiting
-
DeuterOncologyRecruitingAdult Solid Tumor | Lung Cancer | Advanced Solid Tumor | Non-small Cell Lung Cancer | Non-small Cell Carcinoma | Refractory Tumor | Hereditary Renal Papillary CancerFrance, Belgium, Netherlands
-
Incyte CorporationActive, not recruitingAdvanced Solid Tumors | Squamous Cell Carcinoma of the Head and Neck (SCCHN) | Gastrointestinal (GI) MalignanciesUnited States, Netherlands, Spain, United Kingdom, Belgium, Austria
-
Francis CorazzaRecruitingBlood Transfusion ComplicationBelgium
-
Universitair Ziekenhuis BrusselUnknownNeutropenia | Childhood CancerBelgium
-
Novartis PharmaceuticalsCompletedMetastatic or Locally Advanced Solid TumorsNetherlands, Spain, Germany, Switzerland, Belgium
-
Novartis PharmaceuticalsNantCell, Inc.TerminatedPIK3CA Mutated Advanced Solid Tumors | PIK3CA Amplified Advanced Solid TumorsSpain, Belgium, United States, Canada
-
Boston PharmaceuticalsCompletedAdvanced Nonhaematologic MalignanciesUnited States, Korea, Republic of, Taiwan, France, Hong Kong, Belgium, Spain
-
Novartis PharmaceuticalsTerminatedSolid TumorsUnited States, Germany, Spain, Belgium, Korea, Republic of, Japan, Italy
-
Novartis PharmaceuticalsCompletedAdvanced Solid Tumors | Metastatic Solid TumorsFrance, Netherlands, Spain, Canada, Singapore, Germany, Korea, Republic of, Australia, Belgium, Switzerland, Italy, United States
-
OSE ImmunotherapeuticsRecruitingDose-finding and Dose Expansion Study of OSE-279 in Subjects With Advanced Solid Tumors or LymphomasLymphoma | Solid Advanced TumorFrance, Belgium
-
AstraZenecaCompletedSolid TumoursBelgium, France, Netherlands, United Kingdom, Denmark